Bedaquiline and the treatment of tuberculosis
The Indian government is lagging behind in the issue of Tuberculosis (TB) treatment according to Harvard Medical School expert, Jennifer Furin in an email interview with The Hindu. The focal point of the matter is India’s lack of access to treatment via Bedaquiline, a drug capable of treating multi-drug resistant TB (MDR-TB). Created in response …
